Publicación:
Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer

dc.contributor.author Castaneda C.A. es_PE
dc.contributor.author Castillo M. es_PE
dc.contributor.author Chavez I. es_PE
dc.contributor.author Barreda F. es_PE
dc.contributor.author Suarez N. es_PE
dc.contributor.author Nieves J. es_PE
dc.contributor.author Bernabe L.A. es_PE
dc.contributor.author Valdivia D. es_PE
dc.contributor.author Ruiz E. es_PE
dc.contributor.author Dias-Neto E. es_PE
dc.contributor.author Landa-Baella M.P. es_PE
dc.contributor.author Bazan Y. es_PE
dc.contributor.author Rengifo C.A. es_PE
dc.contributor.author Montenegro P. es_PE
dc.date.accessioned 2024-05-30T23:13:38Z
dc.date.available 2024-05-30T23:13:38Z
dc.date.issued 2019
dc.description.abstract PURPOSE Helicobacter pylori (HP) and Epstein Barr virus (EBV) infections induce chronic gastritis (CG) and are accepted carcinogenics of gastric cancer (GC). Our objective for this study was to determine the prevalence of these agents and clinicopathological features of GC and CG associated with the infection. PATIENTS AND METHODS A single-center cohort of 375 Peruvian patients with GC and 165 control subjects with CG were analyzed. Evaluation of HP and EBV genes was performed through quantitative polymerase chain reaction. RESULTS Prevalence of HP was 62.9% in the whole population and 60.8% in the GC subset. The cagA gene was detected in 79.9%; vacAs1 and vacAm1 alleles in 41.6% and 60.7%, respectively; and concurrent expression of vacAs1 and vacAm1 in 30.4% of infected patients in the whole series. The prevalence of EBV was 14.1% in the whole population and was higher in GC (P , .001). Coinfection of HP and EBV was found in 7.8% and was also higher in GC in univariate (P , .001) and multivariate (P = .011) analyses. Infection rates of HP and EBV were not associated with a geographic location in the whole series. Few clinicopathological features have been associated with infectious status. CONCLUSION Prevalence of HP infection and virulent strains are high in the Peruvian population. Infection by EBV was more frequent in patients with GC. © 2019 by American Society of Clinical Oncology.
dc.description.sponsorship Consejo Nacional de Ciencia, Tecnología e Innovación Tecnológica - Concytec
dc.identifier.doi https://doi.org/10.1200/JGO.19.00122
dc.identifier.scopus 2-s2.0-85071751339
dc.identifier.uri https://hdl.handle.net/20.500.12390/2740
dc.language.iso eng
dc.publisher American Society of Clinical Oncology
dc.relation.ispartof Journal of Global Oncology
dc.rights info:eu-repo/semantics/openAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subject Oncology
dc.subject Cancer Research es_PE
dc.subject.ocde http://purl.org/pe-repo/ocde/ford#3.03.08
dc.title Prevalence of helicobacter pylori infection, its virulent genotypes, and Epstein-Barr virus in peruvian patients with chronic gastritis and gastric cancer
dc.type info:eu-repo/semantics/article
dspace.entity.type Publication
Archivos